Publications
- Effect of baseline central retinal thickness on the results of treatment of diabetic macular edema with aflibercept: real-life evidence in the Czech republic2022 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Artificial intelligence in diabetic retinopathy screening. A review2021 | Third Faculty of Medicine
- Innovative Strategies for Treating Retinal Diseases2019 | Third Faculty of Medicine, First Faculty of Medicine
- One-year follow-up outcomes of the treatment of wet age-related macular degeneration with aflibercept2018 | Third Faculty of Medicine
- Makulární edémy2018 | Third Faculty of Medicine
- Pars plana vitrektomie a pooperační péče2016 | Third Faculty of Medicine
- Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic2023 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine
- Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes2023 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Diabetic Macular Edema - Diagnostics and Treatment Guidelines2023 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial2023 | Third Faculty of Medicine, Central Library of Charles University
Loading network view...